CD200和CD43表达在慢性淋巴细胞白血病与套细胞淋巴瘤鉴别诊断中的作用
The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma.
作者信息
Falay Mesude, Afacan Öztürk Berna, Güneş Kürşad, Kalpakçı Yasin, Dağdaş Simten, Ceran Funda, Özet Gülsüm
机构信息
University Ministry of Health, Ankara Numune Training and Research Hospital, Clinic of Hematology, Ankara, Turkey.
出版信息
Turk J Haematol. 2018 May 25;35(2):94-98. doi: 10.4274/tjh.2017.0085. Epub 2017 Jul 17.
Abstract
OBJECTIVE
Atypical chronic lymphocytic leukemia (CLL) is most frequently confused with mantle cell lymphoma (MCL). Several markers may contribute to the diagnosis of CLL. However, there is no consensus on which markers are needed to be used in flow cytometry for the diagnosis of CLL. The aim of the present study was to investigate the role of CD43 and CD200 markers in the differential diagnosis between CLL and MCL.
MATERIALS AND METHODS
To address this issue, 339 consecutive patients with CLL and MCL were included in the flow cytometry lymphoproliferative disease panel for evaluation of CD43 and CD200 expressions, but not in the Matutes scoring system.
RESULTS
CD200 was expressed in 97.3% of atypical CLL cases, whereas it was dimly expressed in only 6.1% of MCL cases. CD43 expression was 95.7% in atypical CLL cases. In the MCL cases, its expression rate was 39.4%.
CONCLUSION
CD43 and CD200 were found to be more valuable markers than CD22, CD79b, and FMC7. CD43 and CD200 could also be considered as definitive markers in atypical CLL patients, for whom the Matutes scoring system remains ineffective.
摘要
目的
非典型慢性淋巴细胞白血病（CLL）最常与套细胞淋巴瘤（MCL）相混淆。多种标志物可能有助于CLL的诊断。然而，对于在流式细胞术中诊断CLL需要使用哪些标志物尚无共识。本研究的目的是探讨CD43和CD200标志物在CLL与MCL鉴别诊断中的作用。
材料与方法
为解决这一问题，339例连续的CLL和MCL患者被纳入流式细胞术淋巴增殖性疾病检测组，以评估CD43和CD200的表达情况，但未纳入马图特评分系统。
结果
CD200在97.3%的非典型CLL病例中表达，而在仅6.1%的MCL病例中呈弱阳性表达。非典型CLL病例中CD43表达率为95.7%。在MCL病例中，其表达率为39.4%。
结论
发现CD43和CD200是比CD22、CD79b和FMC7更有价值的标志物。对于马图特评分系统仍然无效的非典型CLL患者，CD43和CD200也可被视为确定性标志物。
相似文献
1
The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma.CD200和CD43表达在慢性淋巴细胞白血病与套细胞淋巴瘤鉴别诊断中的作用
Turk J Haematol. 2018 May 25;35(2):94-98. doi: 10.4274/tjh.2017.0085. Epub 2017 Jul 17.
2
Immunophenotyping of Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病的免疫表型分析
Clin Lab. 2017 Oct 1;63(10):1621-1626. doi: 10.7754/Clin.Lab.2017.170406.
3
CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.CD200在通过多参数流式细胞术对成熟B细胞肿瘤进行鉴别诊断中发挥重要作用。
Cytometry B Clin Cytom. 2014 Mar;86(2):98-105. doi: 10.1002/cyto.b.21128. Epub 2013 Oct 8.
4
Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.具有慢性淋巴细胞白血病样特征的套细胞淋巴瘤：一种具有诊断性的类似物和陷阱。
Hum Pathol. 2022 Jan;119:59-68. doi: 10.1016/j.humpath.2021.11.001. Epub 2021 Nov 9.
5
Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.改良 Matutes 评分中包含 CD200 在慢性淋巴细胞白血病诊断中的应用。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Dec 28;47(12):1689-1694. doi: 10.11817/j.issn.1672-7347.2022.220302.
6
A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.一种包含 CD43 和 CD180 的新评分：提高了非典型慢性淋巴细胞白血病的诊断价值。
Cancer Med. 2021 Jul;10(13):4387-4396. doi: 10.1002/cam4.3983. Epub 2021 Jun 1.
7
Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.复合套细胞淋巴瘤和慢性淋巴细胞白血病/小淋巴细胞淋巴瘤。
Cytometry B Clin Cytom. 2018 Jan;94(1):148-150. doi: 10.1002/cyto.b.21512. Epub 2017 Feb 24.
8
Which Markers Should the used for Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System by Flow Cytometry?流式细胞术用于诊断慢性淋巴细胞白血病免疫表型评分系统时应使用哪些标志物？
Clin Lab. 2019 Nov 1;65(11). doi: 10.7754/Clin.Lab.2019.190316.
9
Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping.检测 CD43 和 CD200 表面表达水平可提高 B 细胞淋巴瘤免疫表型分析的准确性。
Cytometry B Clin Cytom. 2020 Nov;98(6):476-482. doi: 10.1002/cyto.b.21936. Epub 2020 Jul 27.
10
The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories.CD200 对 Matutes 评分在有限资源实验室中诊断慢性淋巴细胞白血病的诊断准确性的贡献。
PLoS One. 2021 Feb 19;16(2):e0247491. doi: 10.1371/journal.pone.0247491. eCollection 2021.
引用本文的文献
1
Aberrant Expression of , , , , and in Chronic Lymphocytic Leukemia and Psoriasis Patients Compared to Healthy Volunteers.与健康志愿者相比，慢性淋巴细胞白血病和银屑病患者中[具体基因名称]、[具体基因名称]、[具体基因名称]、[具体基因名称]、[具体基因名称]和[具体基因名称]的异常表达
Cancers (Basel). 2025 Jun 24;17(13):2116. doi: 10.3390/cancers17132116.
2
Building a new score system for the diagnosis and differential diagnosis of typical CLL/SLL, atypical CLL/SLL, and MCL based on the flow cytometry immunophenotyping.基于流式细胞术免疫表型分析建立用于典型慢性淋巴细胞白血病/小淋巴细胞淋巴瘤、非典型慢性淋巴细胞白血病/小淋巴细胞淋巴瘤和套细胞淋巴瘤诊断及鉴别诊断的新评分系统。
Ann Hematol. 2025 Mar;104(3):1807-1819. doi: 10.1007/s00277-025-06231-2.
3
Cluster of Differentiation Markers and Human Leukocyte Antigen Expression in Chronic Lymphocytic Leukemia Patients: Correlations and Clinical Relevance.慢性淋巴细胞白血病患者的分化抗原簇标志物与人类白细胞抗原表达：相关性及临床意义
Curr Issues Mol Biol. 2024 Sep 11;46(9):10008-10025. doi: 10.3390/cimb46090598.
4
The Utility of CD43 and CD200 in Differentiating Chronic Lymphocytic Leukemia from Other Mature B-Cell Neoplasms: A Cross Sectional Study.CD43和CD200在鉴别慢性淋巴细胞白血病与其他成熟B细胞肿瘤中的应用：一项横断面研究
Indian J Hematol Blood Transfus. 2024 Jul;40(3):437-442. doi: 10.1007/s12288-023-01719-1. Epub 2023 Nov 30.
5
[The value of CD200 in differential diagnosis of classic hairy cell leukemia and variant hairy cell leukemia].[CD200在经典型毛细胞白血病和变异型毛细胞白血病鉴别诊断中的价值]
Zhonghua Xue Ye Xue Za Zhi. 2023 Sep 14;44(9):775-779. doi: 10.3760/cma.j.issn.0253-2727.2023.09.013.
6
Preliminary analysis of double-negative T, double-positive T, and natural killer T-like cells in B-cell chronic lymphocytic leukemia.B 细胞慢性淋巴细胞白血病中双阴性 T 细胞、双阳性 T 细胞和自然杀伤 T 样细胞的初步分析。
Cancer Med. 2023 Jun;12(12):13241-13255. doi: 10.1002/cam4.6015. Epub 2023 May 4.
7
A Flow Cytometry Panel for Differential Diagnosis of Mantle Cell Lymphoma from Atypical B-Chronic Lymphocytic Leukaemia.流式细胞术检测用于鉴别诊断套细胞淋巴瘤与不典型 B 慢性淋巴细胞白血病。
Iran Biomed J. 2023 Jan 1;27(1):15-22. doi: 10.52547/ibj.3275.
8
A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry.一种使用流式细胞术免疫表型分析的慢性淋巴细胞白血病新型鉴别诊断算法。
Hematol Transfus Cell Ther. 2023 Apr-Jun;45(2):176-181. doi: 10.1016/j.htct.2021.08.012. Epub 2021 Nov 29.
9
A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.一种包含 CD43 和 CD180 的新评分：提高了非典型慢性淋巴细胞白血病的诊断价值。
Cancer Med. 2021 Jul;10(13):4387-4396. doi: 10.1002/cam4.3983. Epub 2021 Jun 1.
10
CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance.CD200与慢性淋巴细胞白血病：生物学及临床相关性
Front Oncol. 2020 Nov 26;10:584427. doi: 10.3389/fonc.2020.584427. eCollection 2020.
本文引用的文献
1
CD38 expression in CLL: a dynamic marker of prognosis.慢性淋巴细胞白血病中CD38的表达：一种动态的预后标志物。
Leuk Lymphoma. 2014 Jan;55(1):1-2. doi: 10.3109/10428194.2013.789510. Epub 2013 May 7.
2
Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia.慢性淋巴细胞白血病的诊断、检查与管理指南
Br J Haematol. 2012 Dec;159(5):541-64. doi: 10.1111/bjh.12067. Epub 2012 Oct 11.
3
Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.外周血 CD19(+) CD5(+) CLL 样细胞的正常水平：确定 CLL 随访的阈值--GEIL-GOELAMS 研究。
Cytometry B Clin Cytom. 2011 Nov;80(6):346-53. doi: 10.1002/cyto.b.20613. Epub 2011 Oct 4.
4
A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma.一种新型评分系统，结合 CD23、CD20 和 CD38 的表达与血小板计数，可预测套细胞淋巴瘤 t(11;14)易位的存在。
Cytometry B Clin Cytom. 2011 Jul-Aug;80(4):230-7. doi: 10.1002/cyto.b.20590. Epub 2011 Apr 1.
5
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.2008 年世界卫生组织淋巴造血组织肿瘤分类及以后：不断发展的概念和实际应用。
Blood. 2011 May 12;117(19):5019-32. doi: 10.1182/blood-2011-01-293050. Epub 2011 Feb 7.
6
Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping.自动化模式引导的主成分分析与基于专家的 B 细胞慢性淋巴增殖性疾病免疫表型分类：临床免疫表型标准化的重要一步。
Leukemia. 2010 Nov;24(11):1927-33. doi: 10.1038/leu.2010.160. Epub 2010 Sep 16.
7
The role of CD11c expression in the diagnosis of mantle cell lymphoma.CD11c 表达在套细胞淋巴瘤诊断中的作用。
Am J Clin Pathol. 2010 Aug;134(2):271-7. doi: 10.1309/AJCPOGCI3DAXVUMI.
8
CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.CD5 阳性慢性 B 细胞淋巴增生性疾病：一种异质性疾病实体的诊断和预后。
Cytometry B Clin Cytom. 2010;78 Suppl 1(Suppl 1):S35-41. doi: 10.1002/cyto.b.20546.
9
Current treatment standards and emerging strategies in mantle cell lymphoma.套细胞淋巴瘤的现行治疗标准和新策略。
Hematology Am Soc Hematol Educ Program. 2009:542-51. doi: 10.1182/asheducation-2009.1.542.
10
Immunophenotypic variations in mantle cell lymphoma.套细胞淋巴瘤的免疫表型变异
Am J Clin Pathol. 2009 Nov;132(5):699-706. doi: 10.1309/AJCPV8LN5ENMZOVY.
Zotero 插件